Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

State to Get $8.3 Million from Mylan Settlement Accounts That Fund Medicaid to Benefit

Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

State to Get $8.3 Million from Mylan Settlement Accounts That Fund Medicaid to Benefit

Article excerpt

Pennsylvania will receive $8.3 million from the $465 million that Mylan has agreed to pay to settle allegations that it overcharged Medicaid for the EpiPen, Pennsylvania Attorney General Josh Shapiro said Friday.

The generic drug maker announced Thursday that it had settled with the U.S. Justice Department, which alleged Mylan had misclassified the emergency allergy shot as a generic product. That allowed Mylan to pay lower rebates to the Medicaid program and resulted in states paying more for the product. Drug companies must ensure that their products are correctly classified.

Mylan disclosed a tentative settlement in October. On Thursday, the drug maker said it will reclassify the EipPen as a brand name drug and pay higher rebates under Medicaid's drug rebate program, retroactive to April 1, 2017. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.